New study aims to boost cervical cancer care for women with HIV

NCT ID NCT06128304

Recruiting now Knowledge-focused Sponsor: University of California, San Diego Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at better ways to provide cervical cancer screening and treatment to women living with HIV in Nigeria. About 2,400 women will take part. Researchers will compare two sets of strategies to see which works best for getting women screened and treated. The goal is to reduce cervical cancer deaths in this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could show how to effectively combine cervical cancer screening with HIV care in low-resource settings, potentially saving many lives.
What could go wrong: This is an implementation study, not testing a new drug or cure. It may not directly improve health outcomes if the strategies don't work as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer HIV infectious disease Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER HIV

Contacts and locations

Locations

UC San Diego
RECRUITING

La Jolla, California, 92093, United States
University of Nigeria, Nsukka
RECRUITING

Enugu, Enugu State, Nigeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.